疫苗接种状态与COVID-19相关急性呼吸窘迫综合征插管患者死亡率的相关性
该多中心队列研究于2021年6月7日至2022年2月1日纳入265例因COVID-19相关ARDS接受有创机械通气的成人患者,比较完整接种组(插管前完成基础免疫>14天且<5个月,26例)与对照组(未接种、部分接种或完成基础免疫<14天或>5个月,239例)从插管至全因ICU死亡的时间。完整接种组年龄更大、合并症更多,但死亡率更低(61.5% vs 68.2%),校正年龄、合并症和插管当日SOFA评分后HR 0.55(95%CI 0.32-0.94;P=0.03)。作者认为疫苗接种可能对因COVID-19相关ARDS插管的患者也有益,结果或有助于与家属讨论预后。
要点
- 因COVID-19相关ARDS插管的成人中,完整接种组26例死亡16例(61.5%),对照组239例死亡163例(68.2%)。
- 校正年龄、合并症和插管当日SOFA评分后,完整接种与较低死亡率相关:HR 0.55(95%CI 0.32-0.94;P=0.03)。
- 完整接种组年龄更大(中位72.5岁 vs 66.0岁),合并症更多(92.3% vs 66.9%),包括恶性肿瘤(23.1% vs 7.5%)。
- 完整接种组26例中20例(76.9%)接种BNT162b2,6例(23.1%)接种ChAdOx1 nCoV-19。
- 完整接种定义为插管前完成基础免疫>14天且<5个月;此阈值参照美国CDC建议此后接种加强针。
适用人群与场景
- 2021年6月7日至2022年2月1日在学术ICU连续纳入的265例COVID-19成人患者,均因ARDS接受有创机械通气。
- 完整接种组:插管前完成COVID-19基础免疫>14天但<5个月;对照组:未接种、部分接种或完成基础免疫<14天或>5个月。
诊断标准与关键阈值
- 完整接种状态:完成COVID-19基础免疫系列>14天但<5个月(插管前);该时间阈值依据美国CDC指南建议超过该时间接种加强针。
研究设计与关键结果
- 多中心队列研究,265例插管患者(170例男性[64.2%];中位年龄66.0岁[IQR 58.0-76.0岁];26例[9.8%]在完整接种组)。
- 完整接种组26例中20例(76.9%)接种BNT162b2,6例(23.1%)接种ChAdOx1 nCoV-19。
- 完整接种组较对照组年龄更大(中位72.5岁[IQR 62.8-80.0岁] vs 66.0岁[IQR 57.0-75.0岁]),合并症更多(24/26[92.3%] vs 160/239[66.9%]),包括恶性肿瘤(6/26[23.1%] vs 18/239[7.5%])。
- 主要终点为插管至全因ICU死亡时间;完整接种组死亡16/26(61.5%),对照组死亡163/239(68.2%);HR 0.55(95%CI 0.32-0.94;P=0.03)。
- Cox比例风险回归模型纳入疫苗接种状态、年龄、合并症和插管当日基线SOFA评分。
证据类型、等级与局限
- 证据类型:多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,完整接种状态与较低死亡率相关,提示疫苗接种可能对因COVID-19相关ARDS插管的患者也有益。
- 作者认为,这些结果或有助于与家属讨论预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Although vaccination substantially reduces the risk of severe COVID-19, it is yet unknown whether vaccinated patients who develop COVID-19 and require invasive mechanical ventilation have lower mortality than controls.
OBJECTIVE: To examine the association between COVID-19 vaccination status and mortality among critically ill patients who require invasive mechanical ventilation owing to acute respiratory distress syndrome (ARDS) related to COVID-19.
DESIGN, SETTING, AND PARTICIPANTS: This multicenter cohort study was performed between June 7, 2021, and February 1, 2022, among 265 consecutive adult patients with COVID-19 in academic intensive care units who underwent invasive mechanical ventilation owing to ARDS.
EXPOSURES: Patients in the full vaccination group had completed the primary COVID-19 vaccination series more than 14 days but less than 5 months prior to intubation. This time threshold was chosen because guidelines from the US Centers for Disease Control and Prevention recommend a booster dose beyond that time. The remaining patients (ie, those who were unvaccinated, partially vaccinated, or fully vaccinated <14 days or >5 months before intubation) comprised the control group.
MAIN OUTCOMES AND MEASURES: The primary outcome was time from intubation to all-cause intensive care unit mortality. A Cox proportional hazards regression model including vaccination status, age, comorbid conditions, and baseline Sequential Organ Failure Assessment score on the day of intubation was used.
RESULTS: A total of 265 intubated patients (170 men [64.2%]; median age, 66.0 years [IQR, 58.0-76.0 years]; 26 [9.8%] in the full vaccination group) were included in the study. A total of 20 patients (76.9%) in the full vaccination group received the BNT162b2 vaccine, and the remaining 6 (23.1%) received the ChAdOx1 nCoV-19 vaccine. Patients in the full vaccination group were older (median age, 72.5 years [IQR, 62.8-80.0 years] vs 66.0 years [IQR, 57.0-75.0 years]) and more likely to have comorbid conditions (24 of 26 [92.3%] vs 160 of 239 [66.9%]), including malignant neoplasm (6 of 26 [23.1%] vs 18 of 239 [7.5%]), than those in the control group. Full vaccination status was significantly associated with lower mortality compared with controls (16 of 26 patients [61.5%] died in the full vaccination group vs 163 of 239 [68.2%] in the control group; hazard ratio, 0.55 [95% CI, 0.32-0.94]; P = .03).
CONCLUSIONS AND RELEVANCE: In this cohort study, full vaccination status was associated with lower mortality compared with controls, which suggests that vaccination might be beneficial even among patients who were intubated owing to COVID-19-related ARDS. These results may inform discussions with families about prognosis.
参考来源
- Grapsa E, Adamos G, Andrianopoulos I, et al. Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome. JAMA Netw Open. 2022. PMID: 36205996. doi:10.1001/jamanetworkopen.2022.35219
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。